Simultaneously, the role of the SNHG17/miR-452-3p/CXCR4 axis in IS warrants further exploration and study, with the hope of uncovering additional therapeutic targets to bring more treatment options to stroke patients. This evidence concerns the gene CXCR4 and Stroke.